UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.27% |
| 2 | Technology | 10.83% |
| 3 | Healthcare | 6.32% |
| 4 | Consumer Discretionary | 6.26% |
| 5 | Financials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
VanEck BDC Income ETF
BIZD
$1.57B
| $2.55M | ﹤0.01% |
209,929
+27,348
| +15% | +$303K |
|
2652
CALL
Blackstone
BX
$89.5B
| $2.55M | ﹤0.01% |
45,000
| – | – |
|
2653
BlackRock MuniYield Michigan Quality Fund
MIY
$341M
| $2.55M | ﹤0.01% |
187,727
+72,439
| +63% | +$952K |
|
2654
Karyopharm Therapeutics
KPTI
$39.7M
| $2.54M | ﹤0.01% |
8,955
+8,467
| +1,735% | +$2.5M |
|
2655
CALL
Sibanye-Stillwater
SBSW
$7.47B
| $2.54M | ﹤0.01% |
294,000
+100,000
| +52% | +$762K |
|
|
GRMN
2656
PUT
Garmin
GRMN
$55.5B
| $2.54M | ﹤0.01% |
26,000
+14,000
| +117% | +$1.2M |
|
2657
Columbia Sportswear
COLM
$2.91B
| $2.53M | ﹤0.01% |
31,393
+1,272
| +4% | +$92.7K |
|
2658
Apogee Enterprises
APOG
$768M
| $2.53M | ﹤0.01% |
109,763
+52,401
| +91% | +$1.07M |
|
2659
CALL
Williams Companies
WMB
$87B
| $2.52M | ﹤0.01% |
132,700
+29,700
| +29% | +$553K |
|
|
SAGE
2660
DELISTED
Sage Therapeutics
SAGE
| $2.52M | ﹤0.01% |
60,527
+45,934
| +315% | +$1.67M |
|
2661
Kinsale Capital Group
KNSL
$7.73B
| $2.52M | ﹤0.01% |
16,207
+1,099
| +7% | +$146K |
|
|
TCF
2662
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.52M | ﹤0.01% |
85,510
+41,864
| +96% | +$1.16M |
|
|
ARI
2663
Apollo Commercial Real Estate
ARI
$805M
| $2.51M | ﹤0.01% |
256,187
+141,283
| +123% | +$1.2M |
|
|
BGIO
2664
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
| $2.51M | ﹤0.01% |
300,930
-34,656
| -10% | -$277K |
|
2665
RGC Resources
RGCO
$215M
| $2.51M | ﹤0.01% |
103,892
+5,393
| +5% | +$137K |
|
2666
Genpact
G
$5.69B
| $2.51M | ﹤0.01% |
68,713
-11,600
| -14% | -$392K |
|
|
GRFS
2667
Grifois
GRFS
$4.9B
| $2.51M | ﹤0.01% |
137,588
+95,041
| +223% | +$1.89M |
|
2668
iShares MSCI Denmark ETF
EDEN
$183M
| $2.5M | ﹤0.01% |
33,927
+29,000
| +589% | +$1.97M |
|
2669
Schwab Fundamental International Large Company Index ETF
FNDF
$26.3B
| $2.5M | ﹤0.01% |
105,297
-20,115
| -16% | -$454K |
|
2670
Nutanix
NTNX
$18.9B
| $2.5M | ﹤0.01% |
105,402
+6,491
| +7% | +$134K |
|
2671
Levi Strauss
LEVI
$7.55B
| $2.49M | ﹤0.01% |
186,173
+61,919
| +50% | +$812K |
|
2672
Protolabs
PRLB
$2.13B
| $2.49M | ﹤0.01% |
22,156
+3,256
| +17% | +$334K |
|
2673
iShares Asia 50 ETF
AIA
$5B
| $2.49M | ﹤0.01% |
38,372
-152,596
| -80% | -$9.21M |
|
|
TMX
2674
DELISTED
Terminix Global Holdings, Inc.
TMX
| $2.49M | ﹤0.01% |
69,724
-56,089
| -45% | -$1.73M |
|
2675
Ultragenyx Pharmaceutical
RARE
$1.47B
| $2.48M | ﹤0.01% |
31,719
-99,111
| -76% | -$6.56M |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $9.52B in Q2 2020, closing 776 positions and reducing 4,000 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 705 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.